Q BioMed Inc
OTC:QBIO
Q BioMed Inc
OTC:QBIO
Price:
0.0001
USD
Market Closed
Market Cap:
$145.1
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Q BioMed Inc
OTC:QBIO
|
US |
|
S
|
Swarnsarita Jewels India Ltd
BSE:526365
|
IN |
|
S
|
Simris Group AB
STO:SIMRIS B
|
SE |
|
V
|
Valencia Capital Inc
XTSX:VAL.P
|
CA |
|
T
|
Tuniu Corp
F:0TUA
|
CN |
|
Gelum Resources Ltd
OTC:GMRCF
|
CA |
|
D
|
Dhanuka Realty Ltd
NSE:DRL
|
IN |
Income Statement
Earnings Waterfall
Q BioMed Inc
Q BioMed Inc
Income Statement
Q BioMed Inc
Q BioMed Inc
Currency: USD
| Nov-2014 | Feb-2015 | May-2015 | Aug-2015 | Nov-2015 | Feb-2016 | May-2016 | Aug-2016 | Nov-2016 | Feb-2017 | May-2017 | Aug-2017 | Nov-2017 | Feb-2018 | May-2018 | Aug-2018 | Nov-2018 | Feb-2019 | May-2019 | Aug-2019 | Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+100%
|
0
-25%
|
0
+33%
|
0
+75%
|
0
+43%
|
0
+100%
|
0
+40%
|
0
+43%
|
0
-5%
|
0
-26%
|
0
-25%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-700%
|
(0)
-88%
|
(0)
-10%
|
(0)
+6%
|
(0)
+35%
|
(0)
+75%
|
(0)
+80%
|
0
N/A
|
0
-11%
|
(0)
N/A
|
(0)
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(4)
|
(5)
|
(6)
|
(6)
|
(8)
|
(10)
|
(12)
|
(13)
|
(12)
|
(11)
|
(9)
|
(9)
|
(9)
|
(8)
|
(8)
|
(12)
|
(11)
|
(11)
|
(13)
|
(9)
|
(10)
|
(9)
|
(7)
|
(6)
|
(5)
|
(5)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(8)
|
(9)
|
(9)
|
(9)
|
(8)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
(9)
|
(9)
|
(10)
|
(11)
|
(8)
|
(7)
|
(7)
|
(6)
|
(5)
|
(5)
|
(4)
|
(3)
|
(3)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-50%
|
(1)
-1 483%
|
(3)
-203%
|
(4)
-27%
|
(5)
-43%
|
(6)
-22%
|
(6)
-1%
|
(8)
-30%
|
(10)
-26%
|
(12)
-18%
|
(13)
-3%
|
(12)
+7%
|
(11)
+6%
|
(9)
+19%
|
(9)
+1%
|
(9)
-3%
|
(8)
+14%
|
(8)
-1%
|
(12)
-54%
|
(11)
+10%
|
(12)
-4%
|
(13)
-13%
|
(10)
+26%
|
(10)
-2%
|
(9)
+7%
|
(7)
+20%
|
(6)
+16%
|
(5)
+14%
|
(5)
+16%
|
(3)
+23%
|
(3)
+21%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(1)
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
3
|
3
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-50%
|
(1)
-1 717%
|
(3)
-210%
|
(4)
-23%
|
(6)
-41%
|
(7)
-23%
|
(8)
-17%
|
(10)
-25%
|
(13)
-22%
|
(15)
-14%
|
(13)
+9%
|
(12)
+6%
|
(11)
+8%
|
(9)
+18%
|
(9)
-2%
|
(10)
-9%
|
(10)
+4%
|
(10)
-4%
|
(14)
-35%
|
(13)
+7%
|
(13)
+2%
|
(13)
-8%
|
(10)
+26%
|
(10)
0%
|
(10)
+5%
|
(8)
+14%
|
(8)
+2%
|
(7)
+8%
|
(6)
+13%
|
(2)
+68%
|
(0)
+76%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(4)
|
(6)
|
(7)
|
(8)
|
(10)
|
(13)
|
(15)
|
(13)
|
(12)
|
(11)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(14)
|
(13)
|
(13)
|
(13)
|
(10)
|
(10)
|
(10)
|
(8)
|
(8)
|
(7)
|
(6)
|
(2)
|
(0)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
-50%
|
(1)
-1 717%
|
(3)
-210%
|
(4)
-23%
|
(6)
-41%
|
(7)
-23%
|
(8)
-17%
|
(10)
-25%
|
(13)
-22%
|
(15)
-14%
|
(13)
+9%
|
(12)
+6%
|
(11)
+8%
|
(9)
+18%
|
(9)
-2%
|
(10)
-9%
|
(10)
+4%
|
(10)
-4%
|
(14)
-35%
|
(13)
+3%
|
(13)
+1%
|
(14)
-8%
|
(11)
+23%
|
(11)
+4%
|
(10)
+5%
|
(9)
+14%
|
(9)
+2%
|
(8)
+2%
|
(8)
+6%
|
(3)
+56%
|
(2)
+46%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.05
-25%
|
-0.04
+20%
|
0
N/A
|
-0.12
N/A
|
-0.38
-217%
|
-0.47
-24%
|
-0.66
-40%
|
-0.81
-23%
|
-0.88
-9%
|
-1.05
-19%
|
-1.17
-11%
|
-1.39
-19%
|
-1.03
+26%
|
-0.88
+15%
|
-0.8
+9%
|
-0.67
+16%
|
-0.66
+1%
|
-0.72
-9%
|
-0.68
+6%
|
-0.68
N/A
|
-0.68
N/A
|
-0.6
+12%
|
-0.59
+2%
|
-0.65
-10%
|
-0.44
+32%
|
-0.4
+9%
|
-0.36
+10%
|
-0.33
+8%
|
-0.26
+21%
|
-0.25
+4%
|
-0.17
+32%
|
-0.08
+53%
|
-0.01
+88%
|
|
Switch to:
Switch to:
See Also
Discover More
